Trial Details

TERMINATED
Basic Information
Clinical ID c1230
Identifier NCT02142725
Trial Title Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: LT-02|DRUG: LT-02|DRUG: Placebo
Participant Information
Sponsor Dr. Falk Pharma GmbH
City Frankfurt a.M.
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2014-07-21
Primary Completion Date 2016-11-11
Completion Date 2016-12-16